Telerehabilitation as Follow-up for Obesity

NCT ID: NCT06871436

Last Updated: 2025-03-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

138 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-04-07

Study Completion Date

2026-08-07

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this experimental study is to observed the impact of telerehabilitation modalities in obese patient after a hospitalization on physical intensity at home (MVPA). The secondary aim is to observe the evolution of clinical parameters such as anthropometric data, adherence and psychological state.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Obese Patients

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Supervised Telerehabilitation

Participants will have access to the Follow SURG application to monitor their health at home. In addition, participants will be asked to wear the activity wristband daily (except when sleeping) and to download the GARMIN Connect app on their smartphone to update their physical activity data. They will participate in telerehabilitation sessions with a professional via videoconference using the AXOMOVE telehealth application.

These sessions will take place three times a week, for 60 minutes, from 12pm to 13pm and 5pm to 6pm on Mondays, Wednesdays and Fridays. Each telerehabilitation group will follow these sessions live. Telerehabilitation sessions include a 10-minute warm-up, 40 minutes of circuit training, 5 minutes of stretching and 5 minutes of discussion with the professional.

Group Type EXPERIMENTAL

Aerobic Exercice and muscular reinforcement

Intervention Type OTHER

Aerobic exercise and muscle strengthening to increase weekly physical activity at moderate and vigorous intensities

Unsupervised Physical Activity Videos

Participants will be able to use the Follow SURG application to monitor their health at home. In terms of accessibility, this will be comprehensive, with access to informative content proposed by paramedical professionals such as psychomotricians, dieticians and psychologists, as well as content made available in the current COBD follow-up. In addition, participants will be asked to wear the activity wristband on a daily basis (except when sleeping) and to download the GARMIN Connect application onto their smartphone in order to update their PA data. Participants will be asked to carry out APA sessions 3 times a week, using videos produced in advance by a professional. Videos will include 10 min of warm-up, 40 min of circuit training (following the same modalities as those defined in the "Telerehabilitation" section) and 10 min of stretching.

Group Type EXPERIMENTAL

Aerobic Exercice and muscular reinforcement

Intervention Type OTHER

Aerobic exercise and muscle strengthening to increase weekly physical activity at moderate and vigorous intensities

Contrôle Group

Participants will be able to use the Follow SURG application to monitor their health at home. Access to the Follow SURG application will be restricted to informative content provided by paramedical professionals such as psychomotricians, dieticians and psychologists. In addition, participants will be asked to wear the activity wristband on a daily basis (except when sleeping) and to download the GARMIN Connect app on their smartphone in order to update their physical activity data. In addition, reminders to practice physical activity will be provided on the Follow SURG app 3 times a week.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Aerobic Exercice and muscular reinforcement

Aerobic exercise and muscle strengthening to increase weekly physical activity at moderate and vigorous intensities

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Physical activity Exercise muscular reinforcement

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult (\> 18 years old)
* BMI \> 35 or 30 Kg/m2 in case of concomitant comorbidity
* Authorization to practice physical activity for participants over 30 years old by means of a cardiac assessment and an ECG less than 6 months old carried out by a cardiologist. As part of the COBD treatment, the ECG is either: integrated into the patient file before hospitalization if the patient has seen his cardiologist staff. Either the ECG is provided in the file or carried out and analyzed by the center's cardiologist (Dr Rouffaud). The latter then authorizes or not the practice of PA.
* Complete 3-week stay in an obesity center
* Availability of equipment suitable for telerehabilitation at home
* Having given informed consent for participation in the study

Exclusion Criteria

* Medical contraindication to PA practice defined by a doctor
* Participation in a concomitant research protocol
* For women of childbearing age, they will be informed that in the event of pregnancy occurring during participation in the research, they will not be able to continue the protocol and will withdraw from the research
* Refusal to participate in the research protocol
* Patient on weekday stay (\< 3 weeks)
* Psychiatric/psychological disorder limiting the expression of consent
* Persons under legal protection or unable to express their consent
* Inability to participate in any of the 18 Telerehabilitation sessions
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Limoges University

OTHER

Sponsor Role collaborator

Centre de l'Obesite Bernard Descottes

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Claudine VASSEUR, Coordinating doctor

Role: PRINCIPAL_INVESTIGATOR

Centre de l'Obesite Bernard Descottes

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Bernard Descottes Obesity Center

Saint-Yrieix-la-Perche, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Jessica TAVERNIER, Deputy Director

Role: CONTACT

05.19.99.26.26

Clément CHRISTEN, Rehabilitation framework

Role: CONTACT

05.19.99.26.24

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Jessica TAVERNIER, Deputy Director

Role: primary

05.19.99.26.26

Clément CHRISTEN, Rehabilitation framework

Role: backup

05.19.99.26.24

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

N° 2024-A02428-39

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Mobile Health Intervention
NCT02955017 COMPLETED NA
Weight Loss Physical Disabilities
NCT04046471 COMPLETED NA